Literature DB >> 22560982

Detection of phytoconstituents in column fractions of n-hexane extract of Goldcrest honey exhibiting anti-Helicobacter pylori activity.

Christy E Manyi-Loh1, Anna M Clarke, Roland N Ndip.   

Abstract

BACKGROUND AND AIMS: Alternative therapy for Helicobacter pylori eradication from natural products is gaining much attention. This study sought to isolate and characterize the fraction responsible for the antibacterial activity in Goldcrest (GC) n-hexane extract.
METHODS: Thin-layer chromatography (TLC) of the extract was carried out on Silica gel plates to determine the presence of chemical compounds, which were separated and partially purified by column chromatography. The obtained fractions GCCL, GCF2, GCF3 and GCF4 were tested for anti-H. pylori activity using the broth microdilution method. Volatile compounds in the active fractions were identified by gas chromatography-mass spectrometry (GC-MS) analysis. MINITAB was used for statistical analysis at 95% confidence interval.
RESULTS: The best antibacterial activity was exhibited by GCF3 (5 mg/mL), which was composed of many compounds with known antimicrobial and antioxidant properties. A total of 16 volatile compounds were identified from fractions GCF2, GCF3 and GCF4 into the following families; alcohol, ketone, aliphatic acid, benzene compound, hydrocarbon, furan and pyran derivatives.
CONCLUSIONS: The demonstration of antibacterial activity by the column fractions of GC n-hexane extract may provide new lead molecules that could serve as selective agents for H. pylori chemotherapy and control.
Copyright © 2012 IMSS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560982     DOI: 10.1016/j.arcmed.2012.04.006

Source DB:  PubMed          Journal:  Arch Med Res        ISSN: 0188-4409            Impact factor:   2.235


  4 in total

Review 1.  Therapeutic Properties of Bioactive Compounds from Different Honeybee Products.

Authors:  Laura Cornara; Marco Biagi; Jianbo Xiao; Bruno Burlando
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

Review 2.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

3.  Influence of Dietary Factors on Helicobacter pylori and CagA Seroprevalence in Bulgaria.

Authors:  Daniel Yordanov; Lyudmila Boyanova; Rumyana Markovska; Juliana Ilieva; Nikolay Andreev; Galina Gergova; Ivan Mitov
Journal:  Gastroenterol Res Pract       Date:  2017-06-04       Impact factor: 2.260

4.  Allicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis.

Authors:  Xiao-Bei Si; Xu-Min Zhang; Shuai Wang; Yu Lan; Shuo Zhang; Lin-Yu Huo
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.